An update on Tilray. TLRYA short recovery might be on the cards.
This is a reflection using technical analysis + only and we do not consider valuation and macro factors at this stage.
The Fibonacci targets going down are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
Tilray
Looking for further drops on Tilray. TLRYIt was a good run, but now oh it's over now....
Zig zags are happening now. C Wave inbound we believe and we are going down.
Remember, this is not financial advice. You must do your own research and carefully make decisions for yourself by yourself. We love TA and do not provide individually tailored financial advice, or financial advice period.
Now that aside, Fibonacci in crystal clear green and invalidation noted, as always, in red. Good luck out there.
$TLRY 1h tf UPDATE: retest to breakout? or a retest to fakeout?reminders:
1. do not enter without the confirmation.
2. set your stop loss if entering with leverages
3. set your conservative TP
Disclaimer:
a negative catalyst can change a bullish trend
Trade at your own risk
candles may not follow the lines exactly, but it may follow the movement as specified.
Tilray (TLRY) - Weekly chart - Long scenario Looking to buy some Tilray if following should happen:
1. Price goes above the Resistance (orange line)
2. Price should create a higher close than last swing (blue line)
Would buy then on a retest of the yellow trendline.
Target: A weekly supply level also close to 50% Fib level.
Taking out that High (red line) would be interesting from a liquidity aspect.
TILRAY SQUEEZE MAY BE COMING FASTER THAN YOU THINK In my first ever post in tradingview on 15May'21 when cought the falling knife at the exact bottom at $13.41 gave you also the weekly prediction until next May 2022 when I expect Tilray to be above $120 and most probably next stop somewhere between the $121-$153 price range (unless ofcourse EU takes steps for legalization also hence next parabolic arc will be to above $240 and towards new all time high).
In addition to the above I posted a couple of days later (when tilray at $15.01) a daily prediction until end November / Beg December 2021 where I expect Tilray to try to break the 52 week hanging man's high of $67 intraday 10FEB ($77 premarket 11FEB).
However seems to me that the anticipated squeeze will take place by next month and Tilray will break the February high by the end of July'21.
ALL IN
Tilray to $30 -- getting highThis is strictly a technical analysis of Tilray and nothing more -- their financials are garbage and the stock is currently overpriced, but what isn't...
I think RSI is in a good spot on the daily to really run up. Price has been rising along with volume, confirming the market's interest in taking Tilray to higher prices.
First target is $22, and then second target would be $30. I am foreseeing a larger harmonic structure forming here with price rising to $30, which coincides with the .5 fib.
This is not the optimal place to enter this trade, but if you have the kahunas on you, then by all means go ahead and long here.
HEXO DD - The Next Big Cannabis StockMerger Closes Q3 2021
Shareholders Proposal in August 2021
HEXO Acquires Redecan.
www.globenewswire.com
“Redecan’s unwavering focus on the consumer, along with lean operating principles and highly efficient automated manufacturing technology, have allowed us to establish a significant presence in the Canadian market,” said Redecan co-founder Will Montour. “We’ve now entered a phase where scale is key, and our complementary consumer bases, brand portfolios and distribution relationships can enhance financial performance.”
Redecan brings leading manufacturing, automation and packaging capabilities, resulting in some of the most consistent, efficiently produced and innovative products in the industry. Its highly efficient proprietary pre-roll technology has supported some of the highest product gross margins in the industry.
seekingalpha.com
Redecan’s differentiated product portfolio includes top selling oils and capsules, and
leadership in the pre-roll category.
Key is Redecans best in class pre-roll automation of the Redees brand.
redecan.ca
Redees are the Hottest selling preroll in the Ontario Cannabis Store and always out of stock at the local cannabis stores.
Redecan Failed Acquisition.
Alta Vista was to acquire Redecan for 9.5 million in 2015 (before preroll advancements)
Redecan had Previous Acquisition partners in the past including Alta Vista Ventures
investingnews.com
And this tiny cannabis company caught the eye of Bloomberg back in Feb
www.bnnbloomberg.ca
How Redecan quietly became one of Canada's biggest pot companies
* Found by Rick Redekop
* one of the biggest cannabis producers in Canada
* doesn't really have a full-time CEO
* Brother Peter runs production side as well as members of the Hill family, who are behind the Grand River Enterprises tobacco empire, joined Redecan's ownership group.
* Grand River is privately owned cigarette manufacturer empire
* Redecan has no plans to tap public markets, despite getting frequent calls to do so
"If you asked me two years ago, having this unlimited bankroll that some of these other companies had, I would have said, 'Yeah, we would [have gone public.' It would have been nice to have a little bit more money to throw around,” he said. “But I think having that big wallet kind of backfired on a lot of people."
It’s important to understand Redecans history of finding the right deal. If Redecan doesn’t think the merger will work, I would expect a sharp turnaround in HEXO.
Prior Pot Stock Merger
TLRY ran up 172% over the next 30 days to its current support level after the announcement of a merger with Aphria.
TLRY ran another 238% over 26 days during Jan and Feb Gamestop meme stock rally.
Tilray
Market Cap: 7.5B
Shares 450M
P/S 14.10
HEXO
Market Cap: 875M
Shares: 122M
P/S 9.12
If Hexo can enter the US / EU markets It’s reasonable to speculate that HEXO can run to share price of of 16.50 (150% gains) over next 30 days similar to the 170% 30 day run Tilray and Aphria Merger.
PLEASE NOTE - This is NOT FINANCIAL ADVICE! I’m NEW to charting, research, analysis and all aspects of the stock market and equities. These are only my random ideas to learn how to prepare my own long term investments through due diligence.
TILRAY TO ASSIST IN YOUR VOYAGE TO A HIGHER STAGE PART 2 Have received various requests on what is my idea after the Bullish ABC pattern ends up at D to above 120$.
Actually It's difficult to tell since there are many factors which may influence the developments.. I mean if also EU takes steps for legalization by next May 2022 then it will not stop there and form an Arc to above 240$ . If not, then correction should be expected until receive positive news also from the EU later on in the summer of 2023.
Stay strong. Stay Bullish!
TILRAY TO ASSIST IN YOUR VOAYAGE TO A HIGHER STAGE MID TERM IDEAHigh-margin medical cannabis agreements in Europe represent critical waypoints on road to conquer the U.S., bolstering the company’s future balance sheet and putting it on firm footing with European regulators.
As in the U.S., legal recreational cannabis remains on the horizon in Europe, where a combined population of more than 500 million in the U.K. and European Union makes it a lucrative proposition.
News are coming soon for Tilray push into the U.K., Sweden, Poland, Luxembourg, and China, with deal discussions ongoing in India. Tilray will begin distributing even in Luxembourg and businesses pushing into Poland by the third quarter of this year.
In China, the group will have a distribution agreement for wellness products with CBD—a non-psychoactive chemical in cannabis that is used to treat pain and anxiety, among other conditions. A similar agreement is under development in India.
This has the potential to be the Tesla of (Medical) Cannabis and if we can wait for it long term to start making profits then until 2030 we may see new ATH exceeding expectations.
Currently (after a massive short attack) ended up at the current low tens price levels where it can be an accumulation opportunity rarely seen with this potential. .
Enough with the (boring) fundamentals..
Technicaly speaking looks like a bear until it isn't. I will not go through RCI Stochastics MACD or even volume and other indicators which usualy produce false signals depending on the time frame you are looking at. Besides if we are about to start an Elliott wave 5 one may argue that most indicators give pointless divergencies in wave 5 and are only a good consultant up to wave 3.And regarding the volume smart money usualy buy or sell AM or PM so they play/confuse the algos in counting the actual daily volume.
Anyhow I will not go through elliott either since the waves count is no count until they count. Besides Elliott experts say that in commodities there is an exemption and that is: wave 5 may be larger than wave 3. On another note with AI machine learning 90% of MM trading done by Artificial inteligence so maybe no 5 waves exist no more but only 3 waves. and wave 3 may be an Arc that after it bursts shit happens.
So like I said, techicaly speaking looks like a bear until it isn't, however seems to me that we might be near a C bottom of a bullish ABC pattern at low tens (possible Wyckoff accumulation zone or V shape recovery instead - nobody knows - and this is why always better to buy shares instead of gambling with options - it's a Fugazi after all - ) hence Tilray may strongly reverse from here without prior notice.
Remark: This is my first and last idea. I have to continue my voyage. Stay strong. Stay Bullish!
Tilray Inc (NASDAQ: $TLRY): Marijuana Prohibition Boom 2021 🌿🌿Tilray, Inc. is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.
Tilray to ALL TIME HIGH!Im looking for a full legalization of marijuana in the whole western world by 2025.
America and Canada first.
Then Mexico and Europe will follow.
Tilray are the largest company in the sector with the most contacts and legal paperwork in place.
This company will be the largest stakeholder in the market and I believe a market cap of 100B USD isnt an exaggeration.
We're around 4B market cap today so that would take the company from ca 25 usd to 625 usd. = NEW ATH.
This is a long term investment where you should put part of your monthly salary in. Its a company in a growing sector (pun intended) and it will continiue to grow until at least 2030.
Marijuana has 99 more uses than 1(getting high) which will also drive this market to even higher market caps in the future.
Marijuana and hemp can for example be used as BIOFUEL, building material, clothing, and so on.
It has unlimited uses and is ENVORIMENTAL FRIENDLY. Weed will be the new gold in the future.
CANNABIS BACK TO THE MOON?This is not an advice. Just my thoughts about Cannabis stocks. I personally believe in the product too and the market to grow. Tilray is going to merge with Aphria on 14th of april and on 21th of may they will tell their earnings in a report. I hope to see a retest this week to the 23 area. After a break of 23 we can see more up to 30 or even higher. It's also possible it will stay more around this 20 area just like the past two weeks. Be careful because it is a really volatile stock. Set your SL wide enough because this stock moves with ease + or - 6% per day.
I wish everyone good luck and safe trading.
APHRIA head and shouldersAPHRIA had been retesting at 18.80 for a couple days and today finally broke through and dropped a ways. If APHRIA drops to $17.50 and breaks the resistance it will be headed to break the $17 resistance line of the head and shoulders in which we’ll be seeing some lows again around $10 a share which would be good for a long term investment and entry before the 4/20 merger with TLRY. Of course on the other hand the $17 resistance could be strong and we could see Aphria jump from there.